You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
21 November 2025 - Flagship Pioneering, a scientific innovation engine for transformative platforms and products, announced on Thursday that ProFound Therapeutics and Quotient Therapeutics have entered into feasibility agreements with biopharmaceutic...
21 November 2025 - US-based global healthcare company Abbott (NYSE:ABT) announced on Thursday that it has signed a definitive agreement to acquire molecular diagnostics company Exact Sciences (NASDAQ:EXAS), allowing Abbott to enter and lead in fast-g...
20 November 2025 - Clinical-stage biopharmaceutical company Nuvalent Inc (Nasdaq:NUVL) said on Wednesday that the US Food and Drug Administration (FDA) has accepted for filing its New Drug Application (NDA) for zidesamtinib, an investigational ROS1-s...
20 November 2025 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX: 01801) announced on Wednesday that the Phase 3 clinical trial of mazdutide, a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, in C...
19 November 2025 - Norwegian biotechnology company Hemispherian AS announced on Wednesday that the US Patent and Trademark Office has issued a Notice of Allowance for its patent application covering use of its lead clinical candidate, GLIX1, in cance...
19 November 2025 - BioNet, a biotechnology company developing and manufacturing next generation vaccines including recombinant and mRNA vaccines, announced on Tuesday that it has received positive opinion from the Committee for Medicinal Products for...
19 November 2025 - Aetna, a CVS Health company (NYSE:CVS), announced on Tuesday that it is introducing a generative AI-powered conversational experience in its digital channels designed to simplify healthcare.This offering will allow members to quick...